C-MER Medical Holdings Limited (Stock Code: 03309) released a Next Day Disclosure Return dated 21 November 2025, detailing a repurchase of 240,000 ordinary shares from the market at prices ranging between HKD 1.73 and HKD 1.75, totaling HKD 417,640. This transaction reduced the outstanding ordinary shares (excluding treasury shares) from 1,238,912,870 to 1,238,672,870, a 0.0194% decrease, and increased treasury shares from 16,648,000 to 16,888,000. The overall number of shares, including treasury shares, remains 1,255,560,870.

The repurchase was conducted under a mandate passed on 19 May 2025 authorizing the company to repurchase up to 125,556,087 shares.